Geneviéve B. Berger

Geneviéve B. Berger is an Independent Non-Executive Director at Kerry Group Plc since 2023 and an Independent Non-Executive Director at Dassault Systèmes SE since 2023.
Former roles include Chief Executive Officer at Centre National de la Recherche Scientifique in 2003; Independent Non-Executive Director at AstraZeneca PLC from 2012 to 2021; Independent Non-Executive Director at Smith & Nephew plc from 2010 to 2012; Independent Director at Air Liquide SA from 2015 to 2023; Director-Mixed Laboratory at Université Pierre et Marie Curie from 1991 to 2000; Technology Director at France Ministry of National Education, Higher Educ & Research from 1998 to 2000; Director at École normale supérieure Paris-Saclay in 2003; Chief Scientific Officer at Unilever Plc from 2013 to 2014; Chief Research & Development Officer at Unilever NV from 2008 to 2013; Professor at Assistance Publique des Hôpitaux de Paris SA in 2008; Chief Research & Development Officer at Unilever France SAS from 2008 to 2014; Head-Biosphysics & Nuclear Medicine at Religieuses Hospitalières de Saint-Joseph in 2000; Professor at Groupe hospitalier Pitié-Salpêtrière from 2003 to 2008; Chief Science, Research & Development Officer at University Hospitals Pitié Salpêtrière-Charles Foix from 2008 to 2014; Chief Research Officer at Firmenich SA from 2015 to 2021.
Education includes a doctorate from Université Pierre et.
Marie Curie in 1981; an undergraduate degree from École normale supérieure Paris-Saclay in 1978; doctorates from Université de Paris 5 René Descartes in 1985 and 1989.